Cooperative Agreement 72049225CA00002
Award Date
1/6/25
Completion Date
1/5/30
Dollars Obligated
$6.5M
Federal Agency
US Mission in Philippines
Federal Grant Program
98.001
Assistance Type
Cooperative Agreement
Place of Performance
Philippines
Similar Awards
This $7,000,000 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program supports actions to fight tuberculosis (TB) in the Philippines over a 5-year period from October 2024 to September 2029. The project, titled "ACTIONS TO SUPPORT WIDE-SCALE INTERVENTIONS TO FIGHT TB IN THE PHILIPPINES (ACT SWIFT)", will be implemented by the Philippine Tuberculosis Society, Inc. This award...
The U.S. Agency for International Development (USAID) awarded a $6,925,000 Cooperative Agreement under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program to University Research Co., LLC to implement the "TB-FREE LUZON ACTIVITY" in the Philippines. The five-year project, with a start date of September 26, 2024 and a completion date of September 25, 2029, aims to strengthen tuberculosis (TB) prevention and control services in the Luzon region of the Philippines....
This $287,878,180 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program is intended to scale up and improve management of drug-resistant tuberculosis (DR-TB) in USAID-supported countries. The award, which has an ultimate completion date of September 30, 2029, will focus on expanding access to high-quality DR-TB treatment services and providing specialized technical assistance...
This $2,500,000 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance Program (CFDA 98.001) aims to improve the tuberculosis (TB) epidemic response in the high-burden northern and central provinces of Mozambique. The award, effective from July 12, 2024 to July 11, 2029, will be implemented by the Center for Collaboration in Health, a non-profit non-governmental organization based in Maputo, Mozambique. The project seeks to...
This $2,557,380 Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program supports a health TB prevention and response activity in Zimbabwe. The five-year project, running from October 1, 2024 to September 30, 2029, will be implemented by the non-profit organization The Union Zimbabwe Trust. The funding aims to strengthen Zimbabwe's capacity to prevent and respond to tuberculosis (TB) through...
The $3,595,735 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program aims to reduce the burden of tuberculosis (TB), particularly drug-resistant TB, in the Central Asia region within five years. The award, granted to the Dutch non-profit organization Koninklijke Nederlandse Centrale Vereniging Tot Bestrijding DER Tuberculose (Kncv), will support technical expertise,...
The U.S. Agency for International Development (USAID) awarded a $3,347,959 Cooperative Agreement to Right To Care, a non-profit healthcare organization in South Africa, under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) grant program. The award, titled "ACHIEVING AND SUSTAINING HIV/TB EPIDEMIC CONTROL IN THE FREE STATE PROVINCE", is effective from January 17, 2025 to January 16, 2030. The funding supports Right To Care's efforts to provide technical assistance,...
This Cooperative Agreement award, valued at $4,003,313.00, was issued by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) grant program. The purpose of this 5-year award, running from October 2024 to September 2029, is to increase access to and sustainability of quality tuberculosis (TB) diagnosis, treatment, and prevention services in Cambodia through three key objectives: 1) Effective linkages to the healthcare system,...
The U.S. Agency for International Development (USAID) has awarded a 5-year, $7.9 million Cooperative Agreement under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program. The purpose of this activity is to support the strengthening of Tanzania's capacities to develop, validate, and implement interventions to prevent, detect, and respond to emerging infectious diseases. The award was made to the Center for International Health, Education and Biosecurity-Tanzania, a...
The Cooperative Agreement award, titled "USAID'S STRENGTHENING LOCAL LEVEL HEALTH SYSTEM ACTIVITY," is funded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program. The $30,984,000.00 award, with a performance period from August 16, 2024 to August 15, 2029, supports initiatives to strengthen local health systems in Bangladesh. The prime awardee, Research Triangle Institute (RTI International),...